Literature DB >> 513196

Abortive transcription products of vaccinia virus are guanylylated, methylated, and polyadenylylated.

A Gershowitz, B Moss.   

Abstract

Abortive transcription products were synthesized in vitro by UV-irradiated vaccinia virus particles that were incubated with all four ribonucleoside triphosphates or by unirradiated particles that were incubated in reaction mixtures deficient in CTP or UTP. The RNA sedimented at 4 to 6S in sucrose gradients, suggesting that premature termination had occurred, presumably in one case because the DNA contained UV-induced pyrimidine dimers and in the other case because of ribonucleoside triphosphate was present at limiting concentration for transcription. Nevertheless, the short transcripts were capped, methylated, and polyadenylylated, indicating that neither completion of an RNA chain nor processing from a polycistronic precursor was required for modification of either end of the RNA. In addition, the finding of m7G(5')pppAm and m7G(5')pppGm at the 5' ends of the short RNA molecules implied that transcription was initiated with both ATP and GTP. The presence of the polyadenylic acid tract suggested that a slow-down or cessation of transcription, rather than a specific 3'-terminal sequence, served as a signal for polyadenylylation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 513196      PMCID: PMC353514     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Isolation and properties of the vaccinia virus DNA-dependent RNA polymerase.

Authors:  J R Nevins; W K Joklik
Journal:  J Biol Chem       Date:  1977-10-10       Impact factor: 5.157

2.  Use of coupled transcription and translation to study mRNA production by vaccinia cores.

Authors:  H R Pelham
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

3.  Methylated 5'-terminal sequences of vaccinia virus mRNA species made in vivo at early and late times after infection.

Authors:  R F Boone; B Moss
Journal:  Virology       Date:  1977-06-01       Impact factor: 3.616

4.  Enzymatic conversion of 5'-phosphate-terminated RNA to 5'-di- and triphosphate-terminated RNA.

Authors:  E Spencer; D Loring; J Hurwitz; G Monroy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Methyl group analysis of virion-associated high-molecular-weight RNA synthesized in vitro by purified vaccinia virus.

Authors:  D L Nuss; E Paoletti
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

6.  Units of transcription for cytoplasmic RNA in mouse myeloma cells.

Authors:  R Giorno; W Sauerbier
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

7.  Effect of UV irradiation on the expression of vaccinia virus gene products synthesized in a cell-free system coupling transcription and translation.

Authors:  W Bossart; D L Nuss; E Paoletti
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

8.  The role of ATP in the biogenesis of vaccinia virus mRNA in vitro.

Authors:  E Paoletti; B R Lipinskas
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

9.  Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (beta,gamma-imido) triphosphate.

Authors:  A Gershowitz; R F Boone; B Moss
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

10.  Evidence from UV transcription mapping in HeLa cells that heterogeneous nuclear RNA is the messenger RNA precursor.

Authors:  S Goldberg; H Schwartz; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  8 in total

1.  The vaccinia virus A18R protein plays a role in viral transcription during both the early and the late phases of infection.

Authors:  D A Simpson; R C Condit
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

2.  Hybridization selection and cell-free translation of mRNA's encoded within the inverted terminal repetition of the vaccinia virus genome.

Authors:  J A Cooper; R Wittek; B Moss
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

3.  A soluble transcription system derived from purified vaccinia virions.

Authors:  F Golini; J R Kates
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Discriminatory inhibition of protein synthesis in cell-free systems by vaccinia virus transcripts.

Authors:  G Coppola; R Bablanian
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

6.  Poly(riboadenylic acid) preferentially inhibits in vitro translation of cellular mRNAs compared with vaccinia virus mRNAs: possible role in vaccinia virus cytopathology.

Authors:  R Bablanian; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Analysis of vaccinia virus transcriptional complexity in vitro and in vivo: characterization of RNase T1-resistant 5'-terminal oligonucleotides.

Authors:  C Whitkop; B R Lipinskas; S Mercer; D Panicali; E Paoletti
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Biochemical analysis of the multifunctional vaccinia mRNA capping enzyme encoded by a temperature sensitive virus mutant.

Authors:  Jessica Tate; Rachel L Boldt; Baron D McFadden; Susan M D'Costa; Nicholas M Lewandowski; Amber N Shatzer; Paul Gollnick; Richard C Condit
Journal:  Virology       Date:  2015-10-20       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.